Rsv Infection
CDC advisors say some people as young as 50 should get RSV vaccine
CDC advisors recommended this week that the age at which some patients can get vaccinated against respiratory syncytial virus be lowered to 50 years old.
Pediatric RSV Prevention: Critical Insights on Immunoprophylaxis
This activity is supported by an educational grant from Sanofi US.
Pediatric RSV Prevention: Advances in Disease State, Immunization, and Interprofessional Care
This activity is supported by an educational grant from Sanofi US.
Updates in Preventing Pediatric RSV: Rapid Response From IDWeek
This activity is supported by an educational grant from Sanofi US.
Nirsevimab, maternal vaccine reduce medical spending for RSV
Nirsevimab and the maternal vaccine for respiratory syncytial virus can reduce health care costs and productivity losses associated with RSV but lead to higher overall spending, according to analyses published in Pediatrics.
Preventing Pediatric RSV: Latest Strategies in Immunoprophylaxis
This activity is supported by an educational grant from Sanofi US.
Nirsevimab reduces risk for infant RSV
BOSTON — Infants who took nirsevimab had a reduced risk for respiratory syncytial virus lower respiratory tract disease, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
VIDEO: Newest Red Book includes updates on RSV, pneumococcal vaccination
NEW YORK — In this video from the Infectious Diseases in Children Symposium, David W. Kimberlin, MD, provides an overview of the topics that were added to the 2024-2027 Red Book published earlier this year.
Pediatric RSV Prevention – Unlocking New Insights
This activity is supported by an educational grant from Sanofi US.
US has 'embarrassment of riches' to protect children from RSV
This is the second respiratory disease season with two new powerful tools to protect infants from severe respiratory syncytial virus disease, and experts are optimistic that uptake will improve from last season.